Period As Of Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 EKACHAI MEDICAL

Period As Of Details EASTERN TECHNICAL ENGINEERING PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 EASTERN TECHNICAL ENGINEERING PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023

Period As Of Details FN FACTORY OUTLET PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 FN FACTORY OUTLET PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 FN FACTORY OUTLET PUBLIC

Period As Of Details WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023

the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling price per unit (e.g. NAV or NAV+front-end fee) 1.5 Financial statement (if applicable) 1.6 Fund manager and major

registration statement shall have at least the following information: 1.1 Investment objective / policy 1.2 Capital of the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling

/ policy 1.2 Capital of the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling price per unit (e.g. NAV or NAV+front-end fee) 1.5 Financial statement (if applicable) 1.6

following information: 1.1 Investment objective / policy 1.2 Capital of the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling price per unit (e.g. NAV or NAV+front-end fee

September 2019. Details are available at https://bx.in.th/.While https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=7648 SEC Thailand’s public hearing on proposed amendments and draft regulation on the

will be stopped after 30 September 2019. Details are available at https://bx.in.th/.While https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=7648 SEC Thailand’s public hearing on proposed amendments